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Abstract
Background: Diarrheal diseases are a major threat to human health and still represent a leading cause of morbidity
and mortality worldwide. Although the burden of the diarrheal diseases is much lower in developed countries, it is
a significant public health problem in low and middle-income countries like Bangladesh. Though diarrhea is
preventable and managed with low-cost interventions, it is still the leading cause of morbidity according to the
patient who sought care from public hospitals in Bangladesh indicating that significant resources are consumed in
treating those patients. The aim of the study is to capture the inpatients and outpatient treatment cost of diarrheal
disease and to measure the cost burden and coping mechanisms associated with diarrheal illness.
Methods: This study was conducted in six randomly selected district hospitals from six divisions (larger administrative
units) in Bangladesh. The study was performed from the societal perspective which means all types of costs were identified,
measured and valued no matter who incurred them. Cost analysis was estimated using the guideline proposed by the
World Health Organization for estimating the economic burden of diarrheal diseases. The study adopted quantitative
techniques to collect the household and hospital level data including structured and semi-structured questionnaires,
observation checklists, analysis of hospital database, telephone interviews and compilation of service statistics.
Results: The average total societal cost of illness per episode was BDT 5274.02 (US $ 67.18) whereas the average inpatient
and outpatient costs were BDT 8675.09 (US $ 110.51) and BDT 1853.96 (US $ 23.62) respectively. The cost burden was
significantly highest for poorest households, 21.45% of household income, compared to 4.21% of the richest quintile.
Conclusions: Diarrheal diseases continue to be an overwhelming problem in Bangladesh. The economic impact of any
public health interventions (either preventive or promotive) that can reduce the prevalence of diarrheal diseases can be
estimated from the data generated from this study.
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Background
Diarrheal diseases are a global public health problem and a
leading cause of morbidity and mortality across the world.
According to the latest Global Burden of Disease Study,
about 2.39 billion of diarrheal cases occurred globally and
approximately 0.53 million of under five children died every
year [1, 2]. Specifically, incidence and case-fatality ratios are
much higher in lower and middle income (LMI) countries
[3]. In Bangladesh, diarrhea diseases are still very common
among children under 5 years old [4]. In developing coun-
tries, diarrhea-related morbidity and mortality is directly
linked with limited access to potable water and proper sani-
tation system [5]. Several studies observed that epidemics
of diarrheal disease are associated with episodes of flooding
[6], socioeconomic status [7], urban status [8] high popula-
tion density, low education level and the proximity of
household clusters to contaminated surface water [9–11].
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The diseases are highly sensitive to climate, showing sea-
sonal variations in numerous sites [12]. Relative humidity
and temperature influence the rate of replication of differ-
ent types of pathogens such as bacteria and protozoa, and
also the survival of enteroviruses in the environment which
is another cause of diarrheal diseases [13]. Diarrhea is an
alteration in normal bowel movement characterized by an
increase in water content, volume, or frequency of stools
[14]. If the disease lasts “more than 7 days” and “at least
14 days” the term “prolonged” and “persistent” diarrhea is
used respectively [15, 16].
Though diarrhea is preventable and managed with low-
cost interventions, it is still the top cause of morbidity for
patients who sought care from the public hospital system
in Bangladesh [17] and significant resources are expended
in treating these patients. Diarrheal diseases affect people
of all ages irrespective of their socio-economic status and
are particularly prevalent among poor people. A signifi-
cant cause for concern in Bangladesh is that approxi-
mately 26% of the people are below the poverty datum
line. In some cases, the episode can be managed at home
and does not require hospital treatment. However, consid-
ering the direct and indirect cost of households, it repre-
sents a substantial economic burden for the affected
households [18].
There are several studies about the economic burden of
diarrheal disease in many countries [19–25] but know-
ledge about the treatment cost of a full diarrheal episode
is still limited in Bangladesh although such studies are
vital for informing policies and allowing international
comparisons [26, 27]. There are several economic studies
are available focusing diarrheal diseases in Bangladesh
[28–31]. Nevertheless, these studies did not consider the
societal perspective to capture the average cost for diar-
rheal treatment. However, it is essential for policy makers
to understand the precise estimate of the economic cost
of diarrheal treatment based on uniform methodologies
for setting priorities for health sector as well as for
balanced allocation of scarce resources. The intent of this
study is to estimate the age and sex specific economic
costs of diarrheal disease considering a broad social
perspective and to capture the healthcare seeking pattern
during the diarrheal episode in Bangladesh.
Methods
Study setting and sample
This study was conducted in public district hospitals in
Bangladesh. Public hospitals play a major role in provid-
ing treatment for a relatively large population as the
treatment cost in public hospitals is less than private
for-profit hospitals and hospitals financed by non-
governmental organisations (NGOs). A total of 801 diar-
rheal patients were randomly selected and interviewed
from January to December 2015.
Study perspective
The study was a societal perspective which means all
types of costs were identified, measured and valued no
matter who incurred them. The societal perspective is
the summation of provider and household perspective
which is recommended in the current standards for
cost-effectiveness analysis methods [32, 33].
Cost estimates
Cost analysis was estimated using the guideline proposed
by the World Health Organization (WHO) for estimating
the economic burden of diarrheal diseases [34]. A bottom-
up micro-costing approach was used to generate the cost
of illness per episode per patient where all relevant cost
components are identified and valued at the most detailed
level [34, 35].
To capture the household economic cost of illness
both direct and indirect costs were captured. Direct costs
were defined as expenditure during treatment by house-
holds which consists of two parts: direct medical cost
and direct non-medical cost. Direct medical expenses in-
clude those costs consumed for healthcare resources
during diarrheal episodes such as medicine, diagnosis,
registration fees and others. The direct non-medical cost
includes transportation, lodging, food items, informal
payment, payment for helping the patients during treat-
ment. There are other types of expenditure such as
material costs like a mug, jar, plate, glass and other items
such as a coil, lighter and other cost items of patients, as
well as expenditure for people accompanying the
patients and their caregivers to stay outside of hospitals
during diarrheal treatment.
The indirect cost was considered the income loss as
well as productivity loss because of travel to the health
centre and costs due to absence from work because of
illness related to the diarrheal disease. Self-reported wage
rates were used for estimating the income loss. Productivity
costs were estimated using a human capital approach which
reflected the value of all unpaid time devoted to caregiving
themselves, as well as family members and friends [36].
The inclusion of caregiving time based on the assumption
that time dedicated to caregiving may represent foregone
non-market activities such as school, household chores,
child care, and leisure or domestic work [37, 38]. This time
comprised time spent directly on patient care (by the pa-
tient and by unpaid attendants or caregivers), such as at-
tending to diarrhea-related health care appointments. To
capture the productivity losses for non-market activities, we
used the age-specific and occupation-specific wage rates
[38, 39]. We used age-specific wages for adults, teenagers
and children aged 5 to 14 years, where the minimum salary
rate according to national level was given by the adult pa-
tients, one-half for the teenagers and three-quarters to cap-
ture productivity loss for children, however, half of the
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average salary rate assigned to unpaid home workers con-
sidering their age group [38, 39]. Intangible or psychic costs
such as costs related to suffering and grief were not mea-
sured in this study as those costs are not valued in the
disease-specific cost of illness research [38, 40]. Again, time
cost of visitor and extra irregular expense borne by the pa-
tients, caregivers, and visitors on their way during the time
of hospitalization were not included in the analysis. The
household cost burden measured by the percentage of total
household earnings that was consumed by the treatment
cost of diarrheal diseases [41].
The average treatment costs for diarrheal diseases borne
by the public hospitals were measured using the patient-
specific treatment costs approach according to WHO
guidelines [34]. In this aspect, average outpatients and inpa-
tients visits costs were estimated. The costs included costs
of diagnosis, laboratory cost, medicine costs, feeding costs,
institutional cost and other associated costs borne by the
hospitals for treating on a patient-specific basis. Shared
costs were allocated according to the number of patient’s
days of hospitalization. Capital cost was annuitized with 3%
discount rate [35]. The provider actual cost of illness calcu-
lated the provider’s cost for treatment devoid of any fees
received from the patients for hospitalization, drug, diag-
nostic tests, etc. Finally, the societal cost of illness was esti-
mated by adding provider’s actual cost of illness per
patients with the cost incurred per household.
Method of data collection
The study adopted quantitative techniques to collect the
household and hospital level data including the structured
questionnaire, observation checklist, hospital database, tele-
phone interviews and compilation of service statistics. For
household level, respondents were the adult patients or the
accompanying person who was most familiar with the costs
incurred during the treatment of the patient and interviews
were conducted during discharge from the hospital.
Patients’ records drawn from the above Hospital Records
Departments (HRD) were reviewed for the use of resources
for diarrheal patients. Resource utilisation data were
abstracted from the registers for inpatients or outpatients.
At the central level, several offices such as finance, procure-
ment and supply and maintenance unit were contacted to
validate the cost information. A research assistant reviewed
the patient’s records, and data abstraction forms were
updated daily until the discharge of the patient. Finally, a
telephone interview was conducted for taking necessary
information within 1 week after discharge from hospital.
Caregivers were also interviewed in their language of pref-
erence with the use of a standardised interview schedule on
admission or soon thereafter. Questions were asked regard-
ing transportation, consultation before the hospital visit,
medicine brought, expenses during the hospitalization, and
losses of wages resulting from absence from work.
Ethics approval
The research protocol of this study was approved by the
Institutional Review Board of the International Centre
for Diarrheal Disease Research, Bangladesh (icddr,b).
Informed consent was obtained from all respondents
before data collection.
Data analysis
Completed questionnaires were developed by a qualified
supervisor with both numerical and logical checks to minim-
ise errors. Before analysis, missing answers and outliers were
systematically verified. Patient specific cost of illness borne
by the household and provider costs are reported separately.
The data were analysed using a spreadsheet in Microsoft
Excel and Stata/SE 13.0 (StataCorp. College Station, TX,
USA). Proportion, frequencies, rates and ratio, were pre-
sented with a standard deviation in local currency, i.e.,
Bangladeshi Taka (BDT) and US dollars (US$) applying the
exchange rate (US$1 = 78.5 BDT) during the year of the
survey mid 2014- mid 2015 [42]. Like the earlier study, to
test the robustness of the assumption, a sensitivity analysis
was conducted to examine the impact of potential outlier on
the total cost of illness [43]. However, the cost of caregivers
of households had a higher level of uncertainty [44]. For this
purpose, we tested the effect of changes of 20% in the par-
ameter values of both direct and indirect cost of households
and 20% change of both medical and non-medical cost of
the provider as performed in other studies [38, 45].
Results
Background characteristics
A total of 801 patients participated in the study from
selected public district hospitals, among whom 402 and
399 patients were inpatients and outpatients respect-
ively. All respondents participating in this survey were
provided with information about the study, and none with-
held consent. The average age of the patients were
15.46 years (SD = 21.08 years) of which 57.43% were age
under 5 years followed by 24.34% for age ranged 15-45 years.
The highest percentage of patients were homemakers
(38.12%), students (23.75%), self-employed (14.37%) and
only 9.09% of the patients were salaried employees. Approxi-
mately, 31% of the patients had up to secondary grade edu-
cation, and primary school (29.64%). Only 4.19% of the
patients had higher level education whereas 18.56% had no
formal education, and 11.08% had no education (Table 1).
However, diarrheal occurrence was higher among house-
holds with lower parental levels of educational attainment
(Table 1). It was also higher among households with up to 4
to 5 members (43.32%) followed by more than five members
(38.83%), and the average patient’s household size was 3.20
(SD = 0.74) (Table 1). The average monthly income and ex-
penditure of the household were BDT 19,603 (US$ 249.72)
and BDT 15,470 (US$ 197.07) respectively while the average
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Table 1 Background characteristics of the study participants for public tertiary level hospital (N = 801)
Variables Description n (%) / mean ± SD 95% CI (% or mean)
Number of patients N 801
Inpatient 402 (50.19) (46.72, 53.65)
Outpatient 399 (49.81) (46.35, 53.28)
Patient age (%) Up to 4 460 (57.43) (53.09, 59.96)
5 to 14 55 (6.87) (6.08, 9.81)
15 to 45 195 (24.34) (21.49, 27.44)
46 to 60 62 (7.74) (6.08, 9.81)
60+ 29 (3.62) (2.53, 5.17)
Patient age yrs. (mean ± SD) Up to 4 1.41 ± 0.96 (1.32, 1.50)
5 to 14 8.12 ± 2.76 (7.38, 8.87)
15 to 45 29.08 ± 9.43 (27.74, 30.41)
46 to 60 55.47 ± 4.3 (54.38, 56.56)
60+ 75.03 ± 11.99 (70.47, 79.6)
Overall 15.46 ± 21.08 (13.99, 16.92)
Gender (%) Male 404 (50.44) (46.97, 53.9)
Female 397 (49.56) (46.1, 53.03)
Patient Occupation (%) House wife 130 (38.12) (33.09, 43.42)
Students 81 (23.75) (19.51, 28.59)
Self-employment 49 (14.37) (11.02, 18.53)
Unemployed 7 (2.05) (0.98, 4.26)
Salaried employee 31 (9.09) (6.45, 12.66)
Business 18 (5.28) (3.34, 8.24)
Others 25 (7.33) (4.99, 10.64)
Patient education level (%) Illiterate 37 (11.08) (8.17, 15.03)
No formal education 62 (18.56) (14.82, 23.26)
Up to primary 99 (29.64) (24.55, 34.36)
Secondary 103 (30.84) (26.26, 36.23)
Higher secondary 19 (5.69) (3.67, 8.82)
Higher 14 (4.19) (2.51, 7.01)
Mother education level (%) Illiterate 156 (19.48) (16.87, 22.37)
formal education 114 (14.23) (11.98, 16.83)
Up to primary 199 (24.84) (21.97, 27.96)
Secondary 274 (34.21) (30.99, 37.57)
Higher secondary 37 (4.62) (3.36, 6.31)
Higher 21 (2.62) (1.71, 3.99)
Father education level (%) Illiterate 139 (17.35) (14.88, 20.14)
No formal education 139 (17.35) (14.88, 20.14)
Up to primary 191 (23.85) (21.01, 26.93)
Secondary 241 (30.09) (27, 33.36)
Higher secondary 49 (6.12) (4.65, 8.01)
Higher 42 (5.24) (3.9, 7.02)
Household size (%) Less than 2 6 (0.75) (0.34, 1.66)
2 to 3 137 (17.1) (14.65, 19.88)
4 to 5 347 (43.32) (39.92, 46.79)
Sarker et al. Global Health Research and Policy  (2018) 3:1 Page 4 of 12
household healthcare expenditure in the previous 3 months
was BDT 5191 (US$ 66.13) (Table 1).
Distribution of average household cost of illness
Table 2 shows the average cost of illness per diarrheal
episode from the household’s perspective. The average
total costs for treating the diarrhea patients were BDT
4178.68 (US $ 53.23). The average total out-of-pocket
(OOP) cost was BDT 1688.17 (US $ 21.51) which repre-
sented 40% of the total household cost; where 28% was
the direct medical and 12.41% was the direct non-
medical cost. For OOP costs, medicine was the highest
cost driver (BDT 1064.19 or US $13.56) followed by
non-medical transportation cost (BDT 246.58 or US$
3.14). Among the direct medical costs, diagnostic costs
(BDT 37.63 or US$ 0.48) and consultation fee (BDT
26.37 or US $0.34) were the two most significant cost
driver during the episode. However, caregivers expend-
iture (BDT 127.87 or US $1.63) was the critical cost
component of direct non-medical costs, which included
transportation, food, mobile bill and other related
expenses borne by the caregivers during the episodes of
Table 1 Background characteristics of the study participants for public tertiary level hospital (N = 801) (Continued)
Variables Description n (%) / mean ± SD 95% CI (% or mean)
More than 5 311 (38.83) (35.5, 42.26)
Household size 3.20 ± 0.74 (3.15, 3.25)
Patient monthly income, BDT (n = 411) 3976.78 ± 8397.02 (2974.40, 4979.16)
Monthly income of household (BDT) 19,603.37 ± 26,641.74 (17,755.58, 21,451.16)
Monthly expenditure of household (BDT) 15,469.69 ± 10,702 (14,727.43, 16,211.94)
Overall healthcare expenditure last 3 months (BDT) 5191.43 ± 17,745.43 (3960.66, 6422.20)
Income quintile (BDT)
Poorest quintile (≤10,000 BDT) 7963.77 ± 2025.22 (7723.785, 8203.75)
2nd quintile (10,001- 12,000) 11,920.73 ± 266.08 (11,862.27, 11,979.20)
3rd quintile (12,001-18,000) 15,227.71 ± 1253.44 (15,035.63, 15,419.80)
4th quintile (18,001-30,000) 23,540.11 ± 4014.05 (22,961.02, 24,119.20)
Upper quintile (30,000+) 62,188.89 ± 62,881.18 (49,018.68, 75,359.10)
Table 2 Distribution of average household cost of diarrheal treatment for tertiary level hospital (N = 801) BDT (US$)
Cost Parameter Overall cost of treatment Proportion of total cost
Average SD
Direct Medical Diagnostic 37.63 (0.48) 189.71 (2.42) 28
Medicine 1064.19 (13.56) 1427.04 (18.18)
Consultant fee 26.37 (0.34) 121.38 (1.55)
Registration/admission fee 14.54 (0.19) 11.42 (0.15)
Medical materials (syringe/cannula etc) 27.32 (0.35) 62.43 (0.80)
Bed/ Cabin charge 0.28 (0.00) 7.95 (0.10)
Direct Non-Medical Transportation cost 246.58 (3.14) 427.76 (5.45) 12.41
Food items 113.82 (1.45) 239.77 (3.05)
Informal payment 7.40 (0.09) 22.65 (0.29)
Caregiver’s payment 0.01 (0.00) 0.35 (0.00)
Materials (mug/glass etc.) 22.65 (0.29) 70.59 (0.90)
Lodging 0.00 (0.00) 0.01 (0.00)
Caregivers expenditure 127.87 (1.63) 456.80 (5.820
Total direct cost 1688.17 (21.51) 2010.95 (25.62) 40.4
In-direct cost Patient income loss 310.51 (3.96) 1374.40 (17.51)
Caregiver’s income loss 2179.50 (27.76) 3445.12 (43.89)
Total indirect cost 2490.01 (31.72) 3881.48 (49.45) 59.6
Total cost 4178.68 (53.23) 5166.20 (65.81) 100
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diarrhea. For the indirect costs per episode (BDT 2490
or US $ 31.72) caregivers income loss was the highest
(BDT 2, 179.50 or US$ 27.76), higher than patient’s
productivity loss (BDT 310.51 or US$ 3.96).
Household cost and associated variable
Table 3 shows the association between the cost of illness
and the variables of interest. The average household cost of
illness was significant among the age groups. The average
cost of illness (BDT 8407.58 or US$ 107.1) for an elderly
person was comparatively higher than any other age group.
However, the cost of treating under 5 year old children
were significantly lower (BDT 3440.66 or US $ 43.83) than
those aged more than 5 years (BDT 5173.09 or US$ 65.90)
(P < 0.001). The average cost of illness for male patients
(BDT 4441.82 or US$ 56.58) was higher than that of
Table 3 Association between household cost and other variables
Variables Number of patients (N) Household cost, BDT (US $) t / F-statistic P-value
Average SD
Age group (years)
Up to 4 460 3440.66 (43.83) 4549.87 (57.96) 14.43a <0.0001
5 to 14 55 2483.17 (31.63) 3113.52 (39.66)
15 to 45 195 4963.35 (63.23) 4766.65 (60.72)
46 to 60 62 6706.05 (85.43) 8555.34 (108.99)
60+ 29 8407.58 (107.10) 5987.61 (76.28)
Age group under five and others
Under 5 years old patients 460 3440.66 (43.83) 4549.87 (57.96) 4.60b <0.0001
More than 5 years old patients 341 5173.09 (65.90) 5753.68 (73.30)
Sex
Male 404 4441.82 (56.58) 5581.65 (71.10) 1.46b 0.14
Female 397 3909.90 (49.81) 4696.13 (59.82)
Type of care
Inpatient care 402 6570.79 (83.70) 5457.71 (69.52) 14.88b <0.0001
Outpatient care 399 1767.58 (22.52) 3465.92 (44.15)
Income quintile
Poorest quintile (≤10,000) 276 3689.3 (47.00) 4412.93 (56.22) 0.28a 0.89
2nd quintile (10,001- 12,000) 82 4037.95 (51.44) 4785.6 (60.96)
3rd quintile (12,001-18,000) 166 4202.38 (53.53) 4866.93 (62.00)
4th quintile (18,001-30,000) 187 4453.03 (56.73) 5789.56 (73.75)
Upper quintile (30,000+) 90 5189.48 (66.11) 6549.86 (83.44)
For under 5 years old patients
Sex
Male 248 3571.68 (45.50) 4566.33 (58.17) 0.67b 0.505
Female 212 3287.38 (41.88) 4536.52 (57.79)
Type of care
Inpatient care 142 6770.96 (86.25) 4376.74 (55.75) 11.36b <0.0001
Outpatient care 318 1953.54 (24.89) 3777.22 (48.12)
Income quintile
Poorest quintile (≤10,000) 167 3499.31 (44.58) 4596.37 (58.55) 0.28a 0.8919
2nd quintile (10,001- 12,000) 48 3835.03 (48.85) 5304.53 (67.57)
3rd quintile (12,001-18,000) 94 3076.29 (39.19) 3794.47 (48.34)
4th quintile (18,001-30,000) 111 3554.23 (45.28) 5024.53 (64.01)
Upper quintile (30,000+) 40 3263.63 (41.57) 3697.33 (47.10)
aOne-way analysis of variance (ANOVA) was performed to derive significance level
bIndependent two samples t-test was performed to derive significance level
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females (BDT 3909.9 or US$ 49.81) and was not statistically
significant (P = 0.505). Furthermore, the cost of illness for
inpatient care was significantly (P < 0.001) higher (BDT
6570 or US $ 83.7) than that of outpatient care (BDT
1767.58 or US $ 22.52).
Cost burden and coping strategies
The cost burden of diarrheal illness is presented in
Table 4 and the ‘total out of pocket costs’ during treat-
ment is shown as a percentage of the monthly earnings
of the households. The OOP payment as a proportion of
household income differed significantly among the in-
come groups (P < 0.0001). It was observed that during
the treatment course, the most common coping strat-
egies were regular income (85.63%) borrowing from
others (15.63%) and savings (9.38%) (Fig. 1).
The overall OOP expenditure due to diarrheal treatment
was 11.75% of monthly household income. However, in
the poorest quintile, it exceeded 17% of the total house-
hold income. The richest (5th) quintile only spent 4.21%
of their household income. Considering a 10% threshold
level, approximately 32% households suffered from cata-
strophic expenditure while the poorest quintile suffered
more (49%). Even at the highest threshold level of 25%,
the poorest 27% of households suffered from catastrophic
expenditure due to diarrheal diseases (Table 4).
Waiting and travel time
Before coming to the selected public hospitals, most
patients received treatment from other formal and infor-
mal care providers (Fig. 2). However, in LMI countries like
Bangladesh, diarrheal patients are often inadequately
treated at home. Homecare is associated with poor out-
comes and timely medical treatment is the precondition
to minimise the length of each episode and reduce
mortality [46]. The average travel time to the public hos-
pital was nearly 2 h and at least 30 min waiting time be-
fore being attended to.
Inpatient and outpatient cost: Hospital perspective
Table 5 shows the average total inpatient and outpatient
treatment cost due to diarrheal disease. The average
inpatient treatment cost per patient was BDT 2104.09 or
US $ 26.80 whereas direct medical costs constituted only
4.18%. The total direct medical cost per diarrheal
episode was BDT 88.27 or US $ 1.12, and medicine cost
was the largest (BDT 83.23 or US $ 1.06). Among the
direct non-medical costs staff salaries was a major cost
driver (BDT 836.38 or US $ 10.65) followed by capital
costs (BDT 456.31 or US $ 5.81). The other two larger
cost components were food costs (BDT 323.25 or US $
4.12) and space for providing patient services (BDT
321.74 or 4.10).
The average total outpatient cost was BDT 85.97 or
US $1.10 where medical and non-medical costs consti-
tuted 32.56 and 67.44% respectively. Medicine cost
(BDT 28.16 or US $ 0.36) was the main cost driver
followed by the cost of space (BDT 26.20 or US $ 0.33)
and staff salaries (BDT 25.49 or US $ 0.32). A lump
sum amount of capital cost (BDT 4.84 or US $ 0.06)
was also incurred during the treatment course of
outpatients (Table 5).
Societal cost of illness
The average total societal cost of illness per episode was
BDT 5274.02 (US $ 67.18) whereas average inpatient
and outpatient costs were BDT 8675.09 (US $ 110.51)
and BDT 1853.96 (US $ 23.62) respectively (Table 6).
Among all of the cost segments, households cost con-
tributed a larger portion (80% of the total costs) and
Table 4 Cost burden and catastrophic health expenditure in different socioeconomic condition
Income group Direct cost as percentage of
monthly household income
Percentage of household spending for healthcare expenditure as a share
of monthly household income
10% 15% 20% 25%
Poorest quintile (≤10,000) 21.45%
(17.32%-25.58%)
49.20%
(43.66%-54.75%)
40.51%
(35.18% - 46.08%)
31.83%
(26.88% - 37.23%)
27.01%
(22.35% - 32.23%)
2nd quintile
(10,001- 12,000)
11.6%
(9.18%-14.02%)
39.64%
(30.94% - 49.05%)
26.13%
(18.77% - 35.12%)
16.22%
(10.43% - 24.33%)
9.91%
(5.55% - 17.06%)
3rd quintile
(12,001-18,000)
9.35%
(7.92%-10.79%)
31.84%
(26.04%-38.26%)
16.14%
(11.86%-21.59%)
10.31%
(6.94% - 15.06%)
7.17%
(4.43% - 11.41%)
4th quintile
(18,001-30,000)
6.45%
(5.27%-7.64%)
20.62%
(16.10%-26.02%)
10.12%
(6.97% - 14.46%)
5.84%
(3.54% - 9.47%)
2.33%
(1.05% - 5.11%)
Upper quintile
(30,000+)
4.21%
(3.34%-5.08%)
8.22%
(4.71%-13.95%)
4.79%
(2.29% - 9.75%)
4.11%
(1.85% - 8.87%)
1.37%
(0.34% - 5.34%)
Overall 11.75%
(10.37%-13.14%)
31.77%
(29.02% - 34.66%)
21.37%
(18.99% - 23.97%)
15.36%
(13.30% - 17.68%)
11.35%
(9.57% - 13.43%)
Rich–poor ratio 0.196 0.167 0.118 0.129 0.051
Rich–poor difference −17.240 −40.980 −35.720 −27.720 −25.640
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OOP contributed 32% of the total societal cost of illness.
Considering the provider actual treatment cost, the non-
medical cost (19.66%) was the main cost driver. How-
ever, among all of the cost components, the indirect cost
of patients and caregivers (BDT 2490 or US $ 31.72) was
the main cost driver of all types of care which is not
apparent if only provider costs are measured.
Annual economic burden
In the light of the earlier findings this section expresses
the overall economic burden of diarrhea in Bangladesh.
According to the latest national health bulletin, approxi-
mately 2.56 million diarrheal cases and 24 deaths were
reported in 2015 in various health facilities in
Bangladesh [47]. During the hospital based survey,
approximately 44% of the diarrheal patients received
inpatient hospital care, and 66% had outpatient services.
The total annual cost of treatment was US$ 172.02
million for societal perspective while US$ 35.72 million
was incurred by the health facilities.
Discussion
Diarrheal disease is a major public health concern associated
with significant morbidity and mortality and economic loss
in many societies. While the cost of illness for other infec-
tious diseases in Bangladesh has been investigated [38, 48],
knowledge of the cost of illness of diarrheal disease consid-
ering the broader societal perspective is limited. The current
standards for cost-effectiveness analysis recommend to use a
broader societal perspective considering both the provider
and household perspective [33].
We found the average length of the diarrheal episode
is 5 days (results not presented here) which incurred an
average cost of BDT 5274.02 (US $ 67.18) that could be
Fig. 1 Coping mechanisms during diarrheal treatment
Fig. 2 Average travel and waiting time for receiving care
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saved if the diarrheal disease was prevented. More than
52% of the total costs are the direct costs borne by the
households (31%) and hospitals (21%) as the public hos-
pitals are highly subsidised in Bangladesh [49]. In early
2001, Ali et al. found that the provider cost per day for
the management of inpatient and outpatient in a district
hospital (Manikgonj) near Dhaka city was BDT 317.27
or US $ 4.04 and BDT 53.74 or US $ 0.69 respectively
[28]. Das et el estimated that the average inflation ad-
justed diarrheal treatment cost for under 5 year old chil-
dren in rural Bangladesh was US $ 6.99 though they did
not consider the laboratory cost borne by the hospitals
as well as the income loss of the household [29]. From a
multi-country analysis, Rheingans et al. found that the
Table 5 Distribution of provider costs: average inpatient vs outpatient’s cost, BDT (US $)
Cost Parameters Inpatient (N = 402) Outpatient (N = 399)
Amount % of total cost Amount % of total cost
Direct Medical Medicines 83.23 (1.06) – 28.16 (0.36) –
Diagnosis – – – –
Disposable items 5.03 (0.06) – – –
Total Direct Medical 88.27 (1.12) 4.18% 28.16 (0.36) 32.56%
Direct Non-Medical Staff salaries 836.38 (10.65) – 25.49 (0.32) –
Transport 31.39 (0.4) – – –
Food 323.25 (4.12) – – –
Stationery 3.44 (0.04) – 0.1 (−) –
Window shade 1.21 (0.02) – 0.03 (−) –
Electricity 9.96 (0.13) – 0.27 (−) –
Gas bill 0.33 (−) – 0.01 (−) –
Water bill 0.01 (−) – – –
Telephone bill 0.14 (−) – – –
Other Misallocations 31.66 (0.4) – 0.85 (0.01) –
Capital items 456.31 (5.81) – 4.84 (0.06) –
Building 321.74 (4.1) – 26.2 (0.33) –
Total Direct Non-Medical 2015.82 (25.68) 95.82% 57.8 (0.74) 67.44%
Average cost per Patient 2104.09 (26.80) 100% 85.97 (1.1) 100%
Table 6 Societal cost of illness due to diarrheal disease, BDT (US$)
Type of care Perspective Types of cost Amount BDT (US$) Proportion of total cost (patients)
Inpatient Care (n = 402) Provider Direct medical 88.27 (1.12) 1.02
Direct non-medical 2015.82 (25.68) 23.24
Household Out of pocket payment 2760 (35.36) 31.82
Indirect cost 3811 (48.55) 43.93
Societal All costs 8675.09 (110.51) 100%
Outpatient Care (n = 399) Provider Direct medical 28.16 (0.36) 1.52
Direct non-medical 57.8 (0.74) 3.12
Household Out of pocket payment 609 (7.76) 32.85
Indirect cost 1159 (14.76) 62.51
Societal All costs 1853.96 (23.62) 100%
All- patient Care (N = 801) Provider Direct medical 58.21 (0.74) 1.1
Direct non-medical 1036.81 (13.21) 19.66
Household Out of pocket payment 1689 (21.51) 32.02
Indirect cost 2490 (31.72) 47.21
Societal All costs 5274.02 (67.18) 100%
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average household treatment cost for childhood diarrhoa
was US $ 1.82 where direct cost and indirect costs con-
stituted US $ 1.19 and US $ 0.63 respectively in
Bangladesh. The limitations of this study was the rela-
tively small sample size and therefore was not represen-
tative of the country and that the study was conducted
in a surveillance area [30]. An urban slum based study
carried out in Bangladesh where the incidence of diar-
rhea is high and found that the cost of childhood diar-
rhea per episode ranged from BDT 124 (US $ 1.81) to
BDT 276 (US$ 4.00) with an average duration of 3.76 days
of diarrhea [31]. However, all of these studies did not con-
sider the societal perspective and our study expresses a
more complete accounting of all the relevant costs associ-
ated with an episode of diarrhea.
The current study found that the societal cost of ill-
ness per episode was US $ 110.51 for inpatients and US
$ 23.6 for outpatients respectively. Recently, similar find-
ings have been observed in a number of LMI countries.
Aikins et al. in northern Ghana found that from the
health sector perspectives, the average inpatient and out-
patient treatment costs were US $ 97.40 and the US $
4.10 respectively [50]. In Rwanda, the treatment cost per
diarrheal hospitalization was US $101 and 65% of this
cost was borne by households [51]. Another study con-
ducted in several hospitals in Vietnam found that the
average treatment cost per episode was US$ 106.9
whereas indirect costs made up the largest share (51.3%)
followed by the direct medical costs (33.8%) and direct
non-medical costs (14.9%) [52]. The current study esti-
mated the possible costs of providers (both medical and
non-medical) and costs borne by the patients and their
caregivers (both direct and productivity loss) in a stand-
ard hospital-based survey of six district hospitals of each
six divisions in Bangladesh.
The study showed that the treatment cost for outpa-
tients is lower than for inpatients. Although this study
did not capture the cause of treatment-seeking behav-
iour, systemic literature review on the etiology of
diarrhea, Walker et al. found ETEC and V cholerae O1/
O139 to be the most frequently isolated pathogens in
inpatients, whereas in the outpatient setting, salmonella
sp., shigella sp., and E histolytica were commonly found
[53]. Several studies conducted in Bangladesh to isolate
pathogens from diarrheal stools found shigella sp. in
outpatients. However, different types of pathogens such
as salmonella sp., shigella sp., ETEC and V cholerae O1/
O139, rotavirus, giardia, E histolytica, V parahaemolytica
and campylobacter were typically found in the inpatient
setting [54–56]. Further studies are therefore required to
better understand these findings.
Among all patients, adults with diarrhea consumed
significantly more resources than the young which is
consistent with earlier findings that high healthcare
expenditure is associated with increase in age [57].
Diarrheal cost burden was significantly higher for the
poorest than richest households. The main treatment
coping mechanisms was the income of the households
which was the only source of household’s income. How-
ever, the highest cost burden (21.45%) was observed for
poorest quintile than richest (4.21%). Considering the
provider cost of treatment, the main cost driver was staff
salaries (operating expenditure) and the cost of capital
including building cost (investment cost). Some of those
investment costs occurred at the beginning of the pro-
gram and are often not listed in accounts or budget of
the hospitals but nevertheless we consider that they are
real costs and should be accounted for [35].
We estimate the annual economic burden of diarrheal
diseases to be US $ 172.02 million which was 12.28% of
the total health expenditure in Bangladesh [58]. How-
ever, the estimation is based on the reported cases from
health facilities although it is very common that diarrhea
is inadequately managed at household level and is asso-
ciated with high morbidity and mortality. In that sense,
we underestimated the actual burden of diarrheal disease
in Bangladesh. However, the study was unable to com-
pare the total annual economic burden of diarrheal dis-
ease with other settings, however, a literature review of
economic burden of rotavirus disease study in Asian set-
tings showed that the annual economic burden of rota-
virus illness laid between US$ 0.41 million (Uzbekistan)
up to US $ 365 million in China [59], while the annual
economic burden of rotavirus exceeds US $ 72 million
in India [60]. An unpublished estimation showed that
approximately US$ 7.06 million could be saved by pre-
venting rotavirus diseases in Bangladesh [61]. The latest
estimate of the annual GDP per capita in Bangladesh
(2016) was US 1466 which indicated that approximately
4.58% of GDP per capita spent on treating each diarrheal
episode which might be a critical concern as it is the
prime cause of hospital admission in Bangladesh [17, 62].
Therefore, by controlling diarrheal diseases huge amounts
of resources would be saved. Consequently with reduced
number of patients, hospitals could save extra resources
like hospital bed, space, doctor’s time, and other resources
that could be channeled for other purposes. During the
treatment, reliance on OOP expenditures leads to cata-
strophic economic burden for many households. Further,
many poor and vulnerable people cannot afford healthcare
as currently there are no social health protection schemes
in Bangladesh. To reduce financial barriers to healthcare
for the needy and to avoid catastrophic health expendi-
tures, social health protection might be an option which is
the core theme of universal health coverage.
The limitations to this study include the design; as a
cross-sectional study, it was not possible to estimate the
cost variation in light of seasonality such as the
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incidence of usual peaks during the hot and winter sea-
sons in Bangladesh [63]. The treatment of diarrheal dis-
ease relies heavily on households’ treatment patterns and
resources which are not covered in this study [50]. The
current study was conducted among hospitalized
patients, but many diarrheal episodes occurred in the
community which is not captured in this study. The
other limitation was the sample size as only selected
hospitals were considered, albeit on a randomised basis,
and therefore the study might not be representative of
the whole country. We did not collect the information
about severity of diarrheal illness directly, though pa-
tients with severe disease are more likely to be inpatients
that outpatients [64].
Conclusions
In LMI countries like Bangladesh, diarrheal diseases con-
tinue to be an overwhelming problem. Cost analysis of
diarrheal diseases is required for estimating resources for
managing and preventing diarrheal disease. Therefore, the
economic impact of any public health interventions
(either preventive or promotive) that can reduce the
prevalence of diarrheal diseases can be estimated from the
data generated from this study.
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